Day +11 Methotrexate (MTX) Might Reduce the Risk of Engraftment Syndrome (ES) and Acute Graft-Versus-Host Disease (GvHD) After Unrelated Bone Marrow Transplantation (U-BMT) With Reduced-Intensity Conditioning Regimens